The CARGO team is #hiring a Clinical Project Manager. In this role, you’ll support early-phase clinical research trials. Your work will directly support CARGO’s mission to outsmart cancer through the development of next generation CAR T-cell therapies. Come join us! https://lnkd.in/ecdiJQhN #biotechjobs #celltherapy
CARGO Therapeutics’ Post
More Relevant Posts
-
"Come visit our exhibition stands and explore the latest innovations in drug discovery and development! Discover cutting-edge solutions, network with industry leaders, and unlock new opportunities #alcorwealth #alcordrugdiscovery #addp2024 #LifeSciencesSummits #DrugDiscovery #PreclinicalSummits #USADrugDiscoverySummits #DrugDiscoverySummits #EuropeanClinicalTrialSummits #Scientist #DrugDiscovery #Preclinical #Medchem #Biology #Protein #Antibodies #Conference #InPersonEvent #Summit #AI ML #Data #Oncology #DrugDevelopment #Collaboration #Keynote #PanelDiscussion #Oncology #Therapeutics #DrugDesign #SmallMolecules #LargeMolecules #Events #Therapeutics #BigData #Marketing #DigitalMarketing #AIdrug
To view or add a comment, sign in
-
The 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 allows you to connect with companies that have commercialized their products, revealing the medical affairs strategies behind their success in this challenging field. 📘𝗟𝗲𝗮𝗿𝗻 𝗠𝗼𝗿𝗲 𝗶𝗻 𝘁𝗵𝗲 𝗙𝘂𝗹𝗹 𝗘𝘃𝗲𝗻𝘁 𝗚𝘂𝗶𝗱𝗲 - https://ter.li/5jnhcc As many seek to expand therapies beyond oncology, we're also uniting KOLs from various indications to provide a comprehensive roadmap for achieving this. We know many are trying to expand therapies beyond oncology, and that's why we're also 𝘂𝗻𝗶𝘁𝗶𝗻𝗴 𝗞𝗢𝗟𝘀 𝗳𝗿𝗼𝗺 𝘃𝗮𝗿𝗶𝗼𝘂𝘀 𝗶𝗻𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 to give you an extensive roadmap as to how to successfully do this. 💡Don't miss our workshop on '𝘚𝘵𝘳𝘦𝘯𝘨𝘵𝘩𝘦𝘯𝘪𝘯𝘨 𝘙𝘦𝘭𝘢𝘵𝘪𝘰𝘯𝘴𝘩𝘪𝘱𝘴 𝘸𝘪𝘵𝘩 𝘒𝘦𝘺 𝘖𝘱𝘪𝘯𝘪𝘰𝘯 𝘓𝘦𝘢𝘥𝘦𝘳𝘴 & 𝘏𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘗𝘳𝘰𝘷𝘪𝘥𝘦𝘳𝘴 𝘵𝘰 𝘖𝘱𝘵𝘪𝘮𝘪𝘻𝘦 𝘊𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘗𝘳𝘰𝘨𝘳𝘦𝘴𝘴𝘪𝘰𝘯' with Adaptimmune and Aspen Neuroscience, Inc. for end-to-end coverage on this topic.💡 📘𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝘁𝗵𝗲 𝗙𝘂𝗹𝗹 𝗔𝗴𝗲𝗻𝗱𝗮 - https://ter.li/5jnhcc #CellAndGeneTherapyMedicalAffairsSummit
To view or add a comment, sign in
-
"Thrilled to have Robert Marquis, VP of Business Development at Syngene discussing the future of drug discovery and Syngene's pivotal role in shaping it. Market trends and innovation are key drivers in this dynamic landscape. #addp2024 #alcorwealth #alcordrugdiscovery #DrugDiscovery #Syngene #Innovation" #LifeSciencesSummits #DrugDiscovery #PreclinicalSummits #USADrugDiscoverySummits #DrugDiscoverySummits #EuropeanClinicalTrialSummits #Scientist #DrugDiscovery #Preclinical #Medchem #Biology #Protein #Antibodies #Conference #InPersonEvent #Summit #AI ML #Data #Oncology #DrugDevelopment #Collaboration #Keynote #PanelDiscussion #Oncology #Therapeutics #DrugDesign #SmallMolecules #LargeMolecules #Events #Therapeutics #BigData #Marketing #DigitalMarketing #AIdrug
To view or add a comment, sign in
-
Unveiling Growth Opportunities in the Global #OrphanDrug Industry ⚕️ Amidst the landscape of #rarediseases, the quest for innovative treatments intensifies, fueled by a convergence of advancements in #precisionmedicine, #informatics, and #oncology. Frost & Sullivan's latest analysis uncovers how emerging technologies like precision oncology and gene-editing techniques are reshaping the orphan drug (OD) industry. 🔗Dive into our comprehensive perspectives to seize the #growthopportunities in this dynamic sector 👉https://hubs.la/Q02sxhx-0 Robin Joffe | Nitin Naik | Nimisha Iyer | Sowmya Srinath | Unmesh Lal | Sudhakar Mishra | Aarti Natu Chitale | Surbhi Gupta | Sherin George | Shylesh Narayanan
To view or add a comment, sign in
-
Is precision oncology killing more patients than it's saving? Shocking, I know. But hear me out... The latest market analysis reveals a disturbing trend: For almost every successful precision therapy, 3 others fail in late-stage trials. This isn't just burning through billions in R&D. It's burning through patient hope. Here's the kicker: 80% of these failures are due to poor biomarker strategy, not drug efficacy. We're chasing the wrong targets, folks. 🔬 The deep dive into the top 50+ #oncology pipelines shows: - 65% of companies are over-invested in "me-too" PD-1/PD-L1 inhibitors - Only 12+% are seriously exploring multi-omics approaches - A mere 5+% have robust real-world evidence programs The result? A #market saturated with lookalikes, while true innovation stagnates. But it's not all doom and gloom. The analysis identified 3 under-the-radar #biotechs poised to disrupt this pattern. Their secret? Integrating #AI with multi-omics for hyper-personalized trial design. Early results? Staggering. - 40+% reduction in trial failures - 60% improvement in patient outcomes - 2x faster time-to-market The oncology market is at a crossroads. Will you stick with the failing status quo? Or pivot to where the real breakthroughs are happening? The choice is yours. But choose fast. Because in this game, second place is just the first loser. Agree? Disagree? Let's debate. Drop your thoughts below 👇 𝐏.𝐒. 𝐃𝐨𝐧'𝐭 𝐟𝐨𝐫𝐠𝐞𝐭 𝐭𝐨 𝐫𝐞𝐩𝐨𝐬𝐭 ♻️ 𝐭𝐡𝐢𝐬 𝐟𝐨𝐫 𝐨𝐭𝐡𝐞𝐫𝐬. Let's shake up the industry together. #ColorectalCacner #Oncolyst
To view or add a comment, sign in
-
[📢 Partner Event] Call for applications MATWIN accelerating program 🔓 Willing to unlock the full value of your oncology innovation? 👉When applying to the MATWIN accelerating program, you will: ▪️ Assess and increase the potential of your project in the discovery / preclinical development phase from MATWIN coaching process Obtain validation guidelines for your development plan (clinical strategy, indications, milestones, regulatory guidance etc.) from MATWIN International Board), experts in the field and KOLs ▪️ Get ready for the investment phase thanks to numerous individual high added-value MATWIN coaching / mentoring sessions ▪️ Optimize your partnership opportunities with biotechs / pharmas / investors 👉 ELIGIBILITY : ▪️ Open to any European academic team or start-up working on oncology innovative projects ▪️ Preclinical or early clinical stage with validated POC and defined IP ▪️ Projects in the field of therapeutic, diagnostic, medical device, technological platform, AI tools 👉 To learn more about the MATWIN program, watch video interviews of former applicants and get access to a portfolio of supported projects/testimonies on: https://lnkd.in/eFhBsWrJ ❗ Before applying, please contact MATWIN at contact@matwin.fr #oncology #cancer #innovation #research
To view or add a comment, sign in
-
According to the World Health Organization, AI-powered drug discovery platforms have slashed the time and cost of bringing new cancer drugs to market by up to 50%! This remarkable advancement is paving the way for the development of more targeted and effective therapies. By harnessing the power of artificial intelligence, researchers can sift through vast amounts of data and identify promising drug candidates with unprecedented speed and accuracy. This accelerated drug discovery process allows for quicker translation of scientific discoveries into life-saving treatments for cancer patients. #AIinOncology #PrecisionMedicine #CancerResearch #DrugDiscovery #ArtificialIntelligence #MedicalInnovation #HealthTech #PersonalizedMedicine #InnovationInHealthcare #CancerTreatment #HealthcareAI #ClinicalTrials #DigitalHealth #Biotechnology #OncologyResearch
To view or add a comment, sign in
-
The last 3 weeks have been incredible for the Elixir Associates team in terms of Clinical placements. 🙌🎈 We have successfully helped our clients with the following requirements: ➖ Vice President, Clinical Development - Autoimmune ✅ ➖ Senior Director, Clinical Operations - Oncology ✅ ➖ Director, Clinical Operations - Oncology ✅ ➖ Associate Director, Clinical Operations - Oncology ✅ ➖ Clinical Trial Manager - Oncology ✅ ➖ Clinical Research Associate - Obesity ➖ Senior Clinical Trial Associate - Obesity ✅ Great work by Connor Harknett, Jake Couldrick, Thomas Vos, Dan Spencer, Nahum Wood & Carlos Biggemann to build these Clinical teams across California & Massachusetts !!! #ThankYou ✊🔵🟡 #Elixir #Hiring #Biotech #Pharma #Oncology #Hematology #CellTherapy #CNS #Cardiovascular #RareDisease #InfectiousDisease #MedicalAffairs #LifeSciences #QualityAssurnace #Biometrics #Regulatory #Talent #ClinicalOperations #ClinicalDevelopment #Recruiting #ClinicalScience
To view or add a comment, sign in
-
🔬 We're thrilled to offer a glimpse into the Tumor Microenvironment Track at our upcoming Immuno-Oncology Xchange event in Boston! 🎉 📌Secure your spot and register for free: https://bit.ly/4clU9OU Don't miss this opportunity to explore more into tumor microenvironment in immuno-oncology! Connect with industry experts and gain valuable insights! ⭐ Here's the highlights: 📑 Learning from patient-derived autoantibodies to understand human tumor biology and identify new targets. 🗣️ Xingfeng Bao, VP Head of Biology, GV20 Therapeutics 📑 How to overcome suppressive Tumor Microenvironment, Mechanism, Hurdles, and Innovative Therapeutic Modalities. 🗣️ Dharini Shah, Senior Director (Cell Therapy, Oncology), Sanofi 💊 Only available for Senior Scientists and above, from Bio and Pharma companies with a drug pipeline. 💊 🤝 Our Partners ‣ Biorasi ‣ Enable Medicine ‣ Oncocyte Corporation ‣ Flagship Biosciences, Inc. ‣ WuXi Advanced Therapies ‣ CDI Labs ‣ Nona Biosciences * Agenda subject to change. #ImmunoOncology #CancerResearch #Biotech #Pharma #TumorMicroenvironment #BostonEvents #PharmaEvent #NetworkingEvent #IOtherapy #CancerTherapies #OncologyResearch #BostonNetworking #OncologyInnovation #CancerTreatment #PrecisionMedicine #DrugDevelopment #Biopharma #Bioinformatics #MedicalResearch #Healthcare #BostonLifeScience #InnovationInHealth #ClinicalTrials #BiomarkerDiscovery #ScienceNetworking #ResearchCollaboration #BiomedicalScience #PrecisionOncology #HealthInnovation #hubXchange #Xchanges #Roundtable #FreePass #RegisterNow #ComplimenatryPass
To view or add a comment, sign in
-
"Join us for an illuminating presentation by Carlos Pedraza , Associate Vice President of Biology at Sai Life Sciences Ltd, as he shares insights on 'Integrated Drug Discovery and Development Platform at Sai – An End-to-End Solution.' 🌱 Explore the comprehensive approach to drug development and discover how Sai is pioneering innovation in the field. #alcorwealth #addp2024 #alcordrugdiscovery #LifeSciencesSummits #DrugDiscovery #PreclinicalSummits #USADrugDiscoverySummits #DrugDiscoverySummits #EuropeanClinicalTrialSummits #Scientist #DrugDiscovery #Preclinical #Medchem #Biology #Protein #Antibodies #Conference #InPersonEvent #Summit #AI ML #Data #Oncology #DrugDevelopment #Collaboration #Keynote #PanelDiscussion #Oncology #Therapeutics #DrugDesign #SmallMolecules #LargeMolecules #Events #Therapeutics #BigData #Marketing #DigitalMarketing #AIdrug
To view or add a comment, sign in
14,529 followers